RxDoctor Payments Data

Alan Crawford, PA

Dermatology · Ocean Springs, MSNPI 1720048002

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.9% of the total across 393 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 20.4% — the pattern of someone who eats at a lot of different presentations.

$7,162in general payments, 2019–2025

Across 393 payments — averaging $18.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Johnson & Johnson$824
  • Novartis$658
  • Sanofi$606
  • UCB, Inc.$601
  • Lilly USA, LLC$498
  • plus $3K from 23 others

What the payments were for

  • Food & beverage$6,93897%
  • Education$2243%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,162 in reported general payments places this provider in the 60th percentile of 78 dermatology providers in Mississippi.

See all dermatology providers in Mississippi

Medicare billing

Part B allowed, 2024
$293,753
Medicare patients
1,169
Services billed
7,381

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cosentyx Sensoready (2 Pens)Secukinumab23$181,585
Dupixent PenDupilumab33$126,061
Ketoconazole214$3,900
Triamcinolone Acetonide325$3,681
Clobetasol Propionate97$2,975
Metronidazole29$2,564
Fluorouracil39$2,370
Fluocinonide37$1,446
Doxycycline Hyclate96$1,444
Mometasone Furoate67$1,365
Hydroxychloroquine Sulfate19$1,317
Mupirocin128$1,037
Clindamycin Phosphate49$984
CiclopiroxCiclopirox Olamine34$868
Nystatin71$852

Paid to pharmacies, not to this prescriber.

Other dermatology in Ocean Springs

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →